These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
73 related articles for article (PubMed ID: 3860370)
41. Lymphokine-induced cytotoxicity: requirement of two lymphokines for the induction of optimal cytotoxic response. Yang SS; Malek TR; Hargrove ME; Ting CC J Immunol; 1985 Jun; 134(6):3912-9. PubMed ID: 3921614 [TBL] [Abstract][Full Text] [Related]
42. Effect of isotype on internalization and cytotoxicity of CD19-ricin A immunotoxins. van Oosterhout YV; van den Herik-Oudijk IE; Wessels HM; de Witte T; van de Winkel JG; Preijers FW Cancer Res; 1994 Jul; 54(13):3527-32. PubMed ID: 7516821 [TBL] [Abstract][Full Text] [Related]
43. Detection of cytotoxic antibody to erythroblasts. Zaentz SD; Luna JA; Baker AS; Krantz SB J Lab Clin Med; 1977 Apr; 89(4):851-60. PubMed ID: 845485 [TBL] [Abstract][Full Text] [Related]
44. H-2-restricted cytolytic T lymphocytes specific for a subclass of AKR endogenous leukemia virus-induced tumors: correlation of tumor cell susceptibility with expression of the gross cell surface antigen. Green WR J Immunol; 1980 Dec; 125(6):2584-90. PubMed ID: 6159413 [No Abstract] [Full Text] [Related]
45. Elimination of murine erythroleukemic stem cells with a novel anti-erythroid antibody conjugated to ricin A-chain: a model for studies of bone-marrow transplantation therapy. Tonevitsky AG; Mechetner EB; Rozinova EN; Ievleva ES; Poltoranina VS Int J Cancer; 1986 Feb; 37(2):263-73. PubMed ID: 3080377 [TBL] [Abstract][Full Text] [Related]
46. Human erythrocyte antigens. III. Characterization of a panel of murine monoclonal antibodies that react with human erythrocyte and erythroid precursor membranes. Telen MJ; Scearce RM; Haynes BF Vox Sang; 1987; 52(3):236-43. PubMed ID: 3474823 [TBL] [Abstract][Full Text] [Related]
47. Cytotoxicity of a cell-reactive immunotoxin containing ricin A chain is potentiated by an anti-immunotoxin containing ricin B chain. Vitetta ES; Fulton RJ; Uhr JW J Exp Med; 1984 Jul; 160(1):341-6. PubMed ID: 6736871 [TBL] [Abstract][Full Text] [Related]
48. Expression of Ia-like antigens in human erythroid progenitor cells as determined by monoclonal antibodies and heteroantiserum to Ia-like antigens. Belzer MB; Fitchen JH; Ferrone S; Foon KA; Billing RJ; Golde DW Clin Immunol Immunopathol; 1981 Jul; 20(1):111-5. PubMed ID: 6790211 [No Abstract] [Full Text] [Related]
49. K562--a human leukemia cell line with erythroid features. Gahmberg CG; Andersson LC Semin Hematol; 1981 Jan; 18(1):72-7. PubMed ID: 7010612 [No Abstract] [Full Text] [Related]
50. Antibody mediated delivery of toxic molecules to antigen bearing target cells. Raso V Immunol Rev; 1982; 62():93-117. PubMed ID: 6210622 [No Abstract] [Full Text] [Related]
51. Cytogenetic evidence for maturation along both the granulocytic erythroid pathways using premature chromosome condensation. Petković I; Agbor P; Hittelman WN Bone Marrow Transplant; 1989 Dec; 4 Suppl 3():19. PubMed ID: 2534056 [No Abstract] [Full Text] [Related]
52. Elimination of an anaerobic mycoplasma from a human erythroleukemic cell line, K562. Holmes DH; Hinson A; Ades EW Clin Immunol Immunopathol; 1984 Jan; 30(1):165-6. PubMed ID: 6583030 [TBL] [Abstract][Full Text] [Related]
53. Immunoglobulin-mediated cytotoxic effect of ALS-plasma towards erythrocytes: reflexion of a pathogenetic mechanism? Conradi S; Ronnevi LO Adv Exp Med Biol; 1987; 209():7-13. PubMed ID: 3577932 [No Abstract] [Full Text] [Related]
54. Preparation and application of antibodies coupled to the A chain of ricin. Krolick KA; Uhr JW; Vitetta ES Methods Enzymol; 1983; 93():333-8. PubMed ID: 6346013 [No Abstract] [Full Text] [Related]
55. The preparation and cytotoxic properties of antibody-toxin conjugates. Thorpe PE; Ross WC Immunol Rev; 1982; 62():119-58. PubMed ID: 7042536 [No Abstract] [Full Text] [Related]
56. Cell surface antigens on erythroid cells. A comparison of normal and anemic (W/W) mice. Flaherty L; Cantor L; Zimmerman D; Bennett D Dev Biol; 1977 Sep; 59(2):237-40. PubMed ID: 892229 [No Abstract] [Full Text] [Related]
57. Erythrocyte membrane modification in malignant disease of myeloid and lymphoreticular tissues. II. Erythrocyte "mosaicism" in acute erythroleukaemia. Bird GW; Wingham J; Chester GH; Kidd P; Payne RW Br J Haematol; 1976 Jun; 33(2):295-9. PubMed ID: 1063595 [TBL] [Abstract][Full Text] [Related]
58. Natural cytotoxic activity of sipunculid leukocytes on allogenic and xenogenic erythrocytes. Boiledieu D; Valembois P Dev Comp Immunol; 1977 Jul; 1(3):207-16. PubMed ID: 608493 [No Abstract] [Full Text] [Related]
59. [Disorders in the circadian biorhythms of the cell count in the peripheral blood in experimental leukemia]. Pavlova LS; Khar'kovskaia NA; Khrustalev SA; Berezin AA Gematol Transfuziol; 1983 Feb; 28(2):42-5. PubMed ID: 6840504 [No Abstract] [Full Text] [Related]
60. Neutrophils with ring-shaped nuclei in myeloproliferative disease. Stavem P Br J Haematol; 1985 Mar; 59(3):559. PubMed ID: 3855653 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]